These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment. Frumento D; Grossi G; Falesiedi M; Musumeci F; Carbone A; Schenone S Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338677 [TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours. Halatsch ME; Schmidt U; Behnke-Mursch J; Unterberg A; Wirtz CR Cancer Treat Rev; 2006 Apr; 32(2):74-89. PubMed ID: 16488082 [TBL] [Abstract][Full Text] [Related]
32. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways. Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307 [TBL] [Abstract][Full Text] [Related]
33. Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma. Tsigelny IF; Mukthavaram R; Kouznetsova VL; Chao Y; Babic I; Nurmemmedov E; Pastorino S; Jiang P; Calligaris D; Agar N; Scadeng M; Pingle SC; Wrasidlo W; Makale MT; Kesari S Oncotarget; 2017 Apr; 8(14):22370-22384. PubMed ID: 26517684 [TBL] [Abstract][Full Text] [Related]
34. Erlotinib: early clinical development in brain cancer. Addeo R; Zappavigna S; Parlato C; Caraglia M Expert Opin Investig Drugs; 2014 Jul; 23(7):1027-37. PubMed ID: 24836441 [TBL] [Abstract][Full Text] [Related]
35. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme. Jagannathan J; Prevedello DM; Dumont AS; Laws ER Neurosurg Focus; 2006 Apr; 20(4):E8. PubMed ID: 16709039 [TBL] [Abstract][Full Text] [Related]
36. TSPO as a target for glioblastoma therapeutics. Werry EL; Barron ML; Kassiou M Biochem Soc Trans; 2015 Aug; 43(4):531-6. PubMed ID: 26551689 [TBL] [Abstract][Full Text] [Related]
37. Recent medical management of glioblastoma. Johnson DR; Chang SM Adv Exp Med Biol; 2012; 746():26-40. PubMed ID: 22639157 [TBL] [Abstract][Full Text] [Related]
38. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice. Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968 [TBL] [Abstract][Full Text] [Related]
39. The role of octamer binding transcription factors in glioblastoma multiforme. Rooj AK; Bronisz A; Godlewski J Biochim Biophys Acta; 2016 Jun; 1859(6):805-11. PubMed ID: 26968235 [TBL] [Abstract][Full Text] [Related]
40. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model. Daher A; de Groot J Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]